Nifty
Sensex
:
:
18696.10
62868.50
-116.40 (-0.62%)
-415.69 (-0.66%)

Pharmaceuticals & Drugs - Global

Rating :
54/99

BSE: 506690 | NSE: UNICHEMLAB

368.70
02-Dec-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 403.45
  • 403.45
  • 367.10
  • 399.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  582230
  •  2197.08
  •  466.95
  •  212.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,821.16
  • N/A
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,037.42
  • 1.00%
  • 1.11

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.93%
  • 3.12%
  • 30.17%
  • FII
  • DII
  • Others
  • 1.71%
  • 7.52%
  • 6.55%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.62
  • -1.65
  • 4.78

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -8.17
  • 27.40
  • -13.63

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -11.30
  • -57.79
  • -0.53

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.66
  • 0.53
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.64
  • 1.14
  • 0.72

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.31
  • 26.96
  • 31.75

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Net Sales
328.82
290.66
13.13%
309.61
297.91
3.93%
369.95
274.12
34.96%
311.31
326.28
-4.59%
Expenses
347.13
284.03
22.22%
310.57
299.55
3.68%
301.52
255.07
18.21%
311.94
296.17
5.32%
EBITDA
-18.31
6.63
-
-0.96
-1.64
-
68.44
19.05
259.27%
-0.63
30.12
-
EBIDTM
-5.57%
2.28%
-0.31%
-0.55%
18.50%
6.95%
-0.20%
9.23%
Other Income
9.21
2.65
247.55%
7.85
15.81
-50.35%
14.39
7.83
83.78%
14.66
15.61
-6.09%
Interest
4.69
2.15
118.14%
3.01
1.01
198.02%
1.59
1.81
-12.15%
1.36
1.27
7.09%
Depreciation
28.43
22.43
26.75%
24.54
22.12
10.94%
23.30
21.87
6.54%
23.31
20.82
11.96%
PBT
-47.25
-15.30
-
-20.67
-8.96
-
57.93
3.19
1,715.99%
-10.64
23.64
-
Tax
23.41
-2.69
-
2.69
2.45
9.80%
-13.54
3.37
-
2.69
-0.07
-
PAT
-70.67
-12.60
-
-23.37
-11.41
-
71.47
-0.17
-
-13.33
23.71
-
PATM
-21.49%
-4.34%
-7.55%
-3.83%
19.32%
-0.06%
-4.28%
7.27%
EPS
-10.04
-1.82
-
-3.32
-1.63
-
10.15
-0.06
-
-2.00
3.35
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
1,319.69
1,269.83
1,235.14
1,103.71
1,188.19
1,379.90
1,540.06
1,332.65
1,201.79
1,133.45
1,080.80
Net Sales Growth
10.99%
2.81%
11.91%
-7.11%
-13.89%
-10.40%
15.56%
10.89%
6.03%
4.87%
 
Cost Of Goods Sold
447.41
356.91
302.14
308.63
364.19
274.97
188.77
386.97
378.57
332.84
343.06
Gross Profit
872.28
912.92
933.00
795.08
823.99
1,104.93
1,351.28
945.67
823.23
800.61
737.75
GP Margin
66.10%
71.89%
75.54%
72.04%
69.35%
80.07%
87.74%
70.96%
68.50%
70.63%
68.26%
Total Expenditure
1,271.16
1,197.04
1,144.03
1,154.53
1,269.21
1,358.21
1,357.62
1,168.77
1,100.79
955.75
910.06
Power & Fuel Cost
-
78.05
68.89
73.02
76.39
49.23
41.62
38.25
39.39
35.97
31.36
% Of Sales
-
6.15%
5.58%
6.62%
6.43%
3.57%
2.70%
2.87%
3.28%
3.17%
2.90%
Employee Cost
-
330.49
306.97
273.28
238.52
200.64
169.04
255.92
223.20
187.37
164.88
% Of Sales
-
26.03%
24.85%
24.76%
20.07%
14.54%
10.98%
19.20%
18.57%
16.53%
15.26%
Manufacturing Exp.
-
193.21
215.73
232.08
147.23
125.30
103.70
150.54
145.03
137.05
119.15
% Of Sales
-
15.22%
17.47%
21.03%
12.39%
9.08%
6.73%
11.30%
12.07%
12.09%
11.02%
General & Admin Exp.
-
109.60
123.98
147.90
229.37
594.53
744.66
167.66
153.29
127.77
104.73
% Of Sales
-
8.63%
10.04%
13.40%
19.30%
43.09%
48.35%
12.58%
12.76%
11.27%
9.69%
Selling & Distn. Exp.
-
120.68
122.52
116.12
197.24
108.38
107.77
166.84
157.12
134.03
135.93
% Of Sales
-
9.50%
9.92%
10.52%
16.60%
7.85%
7.00%
12.52%
13.07%
11.82%
12.58%
Miscellaneous Exp.
-
8.11
3.81
3.50
16.26
5.16
2.06
2.58
4.19
0.73
135.93
% Of Sales
-
0.64%
0.31%
0.32%
1.37%
0.37%
0.13%
0.19%
0.35%
0.06%
1.01%
EBITDA
48.54
72.79
91.11
-50.82
-81.02
21.69
182.44
163.88
101.00
177.70
170.74
EBITDA Margin
3.68%
5.73%
7.38%
-4.60%
-6.82%
1.57%
11.85%
12.30%
8.40%
15.68%
15.80%
Other Income
46.11
47.51
50.19
91.31
98.41
3,278.19
5.50
19.11
20.72
42.38
16.96
Interest
10.65
6.11
5.12
7.85
7.52
8.01
3.36
2.90
3.04
3.19
3.29
Depreciation
99.58
91.17
84.36
81.67
67.37
50.51
43.52
38.79
41.27
45.72
38.34
PBT
-20.63
23.03
51.82
-49.02
-57.50
3,241.36
141.07
141.31
77.41
171.17
146.07
Tax
15.25
-11.09
17.15
11.97
-33.64
696.23
32.58
29.30
2.13
43.00
32.85
Tax Rate
-73.92%
-48.15%
33.10%
-24.42%
58.50%
21.48%
23.09%
21.27%
2.75%
25.12%
22.49%
PAT
-35.90
34.12
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
PAT before Minority Interest
-35.90
34.12
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-2.72%
2.69%
2.81%
-5.53%
-2.01%
184.44%
7.04%
8.14%
6.26%
11.31%
10.48%
PAT Growth
0.00%
-1.59%
-
-
-
2,245.96%
0.01%
44.10%
-41.26%
13.19%
 
EPS
-5.10
4.85
4.92
-8.66
-3.39
361.52
15.41
15.41
10.69
18.20
16.08

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
2,618.41
2,556.83
2,531.35
2,619.91
2,680.08
1,063.62
954.33
867.52
816.61
727.07
Share Capital
14.08
14.08
14.08
14.08
14.07
18.18
18.17
18.15
18.13
18.09
Total Reserves
2,593.65
2,535.00
2,512.44
2,601.99
2,665.42
1,044.00
935.01
848.52
797.74
707.98
Non-Current Liabilities
143.88
49.16
43.72
10.10
46.46
64.49
76.02
74.21
97.72
94.31
Secured Loans
89.01
0.00
0.00
0.00
0.33
0.44
22.98
20.35
24.65
20.89
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
39.96
30.41
23.51
14.60
10.76
25.33
12.58
8.88
7.64
9.19
Current Liabilities
552.13
505.76
566.73
502.92
463.51
392.62
275.09
211.76
230.32
251.12
Trade Payables
183.19
210.08
250.22
221.41
226.23
210.73
163.95
138.23
150.52
156.63
Other Current Liabilities
135.06
176.97
122.04
68.45
63.03
68.01
60.56
45.86
32.99
36.65
Short Term Borrowings
215.69
100.63
184.03
199.67
150.29
97.62
12.93
1.63
1.04
6.17
Short Term Provisions
18.19
18.09
10.44
13.39
23.97
16.25
37.65
26.05
45.78
51.67
Total Liabilities
3,314.42
3,111.75
3,141.80
3,132.93
3,190.05
1,520.73
1,305.44
1,153.49
1,144.65
1,072.50
Net Block
990.03
880.42
866.06
806.29
574.45
487.22
402.60
415.99
419.29
447.76
Gross Block
1,391.05
1,193.56
1,098.27
975.96
689.74
561.37
439.53
724.65
688.25
675.87
Accumulated Depreciation
401.01
313.14
232.21
169.67
115.29
74.15
36.92
308.66
268.96
228.11
Non Current Assets
1,666.02
1,734.44
1,455.33
1,093.64
853.59
772.27
673.34
589.07
563.97
594.06
Capital Work in Progress
493.81
567.50
330.47
92.39
238.15
249.98
237.13
122.64
90.54
132.20
Non Current Investment
0.28
159.12
134.38
129.20
9.20
9.51
5.54
5.83
5.72
5.72
Long Term Loans & Adv.
165.59
112.89
112.90
56.37
24.05
25.57
28.05
44.61
48.42
8.38
Other Non Current Assets
16.30
14.52
11.52
9.39
7.74
0.00
0.00
0.00
0.00
0.00
Current Assets
1,648.39
1,377.32
1,686.47
2,039.29
2,336.47
748.46
632.11
564.42
580.68
478.44
Current Investments
263.58
236.43
419.10
800.75
895.55
8.00
8.04
35.04
5.67
33.06
Inventories
600.22
538.34
396.54
338.66
272.86
281.71
230.57
207.68
203.49
143.05
Sundry Debtors
495.43
250.27
390.14
436.05
276.92
315.32
220.09
191.58
196.51
206.95
Cash & Bank
114.10
82.45
233.81
200.99
681.46
16.14
20.13
26.96
52.15
24.64
Other Current Assets
175.06
62.21
63.84
68.65
209.68
127.29
153.28
103.17
122.86
70.75
Short Term Loans & Adv.
136.99
207.62
183.04
194.18
145.51
98.80
122.77
82.25
105.67
61.73
Net Current Assets
1,096.27
871.56
1,119.74
1,536.37
1,872.95
355.84
357.02
352.66
350.36
227.32
Total Assets
3,314.41
3,111.76
3,141.80
3,132.93
3,190.06
1,520.73
1,305.45
1,153.49
1,144.65
1,072.50

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
-259.61
32.98
19.82
-327.77
-112.34
68.19
111.91
78.10
86.73
171.23
PBT
21.97
51.48
-48.21
-57.44
3,241.14
141.25
137.68
77.41
171.17
146.07
Adjustment
80.46
65.65
18.79
6.80
-3,207.66
53.31
39.65
35.57
18.74
47.15
Changes in Working Capital
-354.43
-69.78
53.58
-264.94
-146.67
-98.65
-34.16
-16.49
-66.32
13.05
Cash after chg. in Working capital
-252.00
47.35
24.15
-315.57
-113.20
95.91
143.16
96.49
123.58
206.27
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-7.62
-14.36
-4.34
-12.20
0.86
-27.72
-31.25
-18.39
-36.85
-35.04
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
100.12
-73.56
-35.91
-286.01
1,648.33
-127.87
-85.33
-52.34
35.70
-118.45
Net Fixed Assets
-123.27
-327.70
-338.73
-139.02
-107.71
-135.60
154.89
-73.58
38.14
-92.98
Net Investments
134.15
147.92
374.24
-63.59
-889.36
17.40
42.09
-32.73
20.34
-34.14
Others
89.24
106.22
-71.42
-83.40
2,645.40
-9.67
-282.31
53.97
-22.78
8.67
Cash from Financing Activity
191.23
-121.07
-62.30
-2.42
-881.13
59.23
-33.42
-50.95
-94.92
-51.38
Net Cash Inflow / Outflow
31.74
-161.65
-78.40
-616.19
654.86
-0.46
-6.84
-25.19
27.51
1.41
Opening Cash & Equivalents
77.46
231.52
197.05
666.07
11.21
11.67
26.96
52.15
24.64
23.23
Closing Cash & Equivalent
109.20
77.46
231.52
197.05
666.07
11.21
20.13
26.96
52.15
24.64

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
370.38
362.05
358.85
371.69
380.95
116.88
104.93
95.48
90.02
80.27
ROA
1.06%
1.11%
-1.94%
-0.75%
108.06%
7.68%
8.82%
6.55%
11.56%
11.00%
ROE
1.32%
1.37%
-2.37%
-0.90%
136.04%
10.77%
11.92%
8.95%
16.62%
16.34%
ROCE
1.04%
2.12%
-1.49%
-1.77%
162.77%
13.42%
14.97%
9.29%
21.84%
20.13%
Fixed Asset Turnover
0.98
1.08
1.06
1.43
2.21
3.08
2.32
1.71
1.67
1.71
Receivable days
107.17
94.63
136.61
109.51
78.30
63.41
55.72
58.55
64.53
65.42
Inventory Days
163.63
138.14
121.57
93.93
73.33
60.67
59.32
62.03
55.42
50.47
Payable days
201.09
278.03
76.39
73.41
94.97
104.25
52.00
52.61
62.52
65.77
Cash Conversion Cycle
69.71
-45.27
181.78
130.03
56.65
19.82
63.05
67.97
57.43
50.11
Total Debt/Equity
0.13
0.04
0.07
0.08
0.06
0.09
0.04
0.03
0.03
0.04
Interest Cover
4.77
11.12
-5.25
-6.64
405.79
43.00
48.57
26.45
54.66
45.40

News Update:


  • Unichem Lab - Quarterly Results
    11th Nov 2022, 13:24 PM

    Read More
  • Unichem Laboratories gets ANDA approval for Extended Phenytoin Sodium Capsules
    14th Oct 2022, 15:11 PM

    The product will be commercialized from Unichem’s Ghaziabad Plant

    Read More
  • Unichem Laboratories’ arm recalls 18,960 bottles of hypertension drug in US
    6th Oct 2022, 11:07 AM

    The recall is due to product mix-up

    Read More
  • Unichem Laboratories completes sale of 19.97% equity shares in Optimus
    26th Sep 2022, 09:50 AM

    The company has received payment of around Rs 270.98 crore towards completion of sale of first tranche

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.